A recently published study has indicated that eliminating microglia could significantly reduce tau-linked brain damage in mice, providing a path for novel treatments.
Researchers have discovered that more women and less men are diagnosed with amnestic mild cognitive impairment when sex-specific scores are used.
Wireless brain–machine interface technology has been utilized to design an exoskeleton for helping a tetraplegic patient move his limbs.
By manipulating molecular models, researchers discover protein that could accelerate recovery from peripheral nerve injury.
In a recent follow-up study, researchers discovered that when used as a dietary supplement, choline was able to reduce symptoms associated with Alzheimer’s disease in female mice.
For the first time in living animals, researchers have tracked the movement and functional activity of neurons as they wired together into circuits and discovered that motor neurons are the first to send signals.
A recent study has demonstrated that circadian rhythms in mice may control the extent of response to vaccination of CD8 T cells to antigen presentation by dendritic cells.
Epidyolex® has gained approval from the European Commission for seizures associated with Lennox–Gastaut syndrome or Dravet syndrome in patients 2 years of age and older.
High-grade gliomas may be able to wire themselves into the healthy brain, receiving and interpreting electrical signals from normal neurons.
This week in industry includes trials on elenbecestat to be discontinued, ofatumumab demonstrating superiority to Aubagio and the Toca 5 trial results failing to meet primary endpoint.